AI Assisted Continuous Flow Electrochemistry for Pharmaceutical Manufacture

人工智能辅助制药制造的连续流电化学

• 批准号: LP230100436
• 负责人: A/Prof Anastasios Polyzos
• 金额: $ 20.76万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2024
• 资助国家: 澳大利亚
• 起止时间: 2024-01-01 至 2025-12-31
• 项目状态: 未结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP230100436
• 关键词: AI; Assisted; Continuous; Flow; Electrochemistry

This project aims to develop new chemical manufacturing processes for pharmaceutical products. In collaboration with Sun Pharma, it will tackle the challenge of replacing expensive and toxic chemicals in industrial reactions, to lower cost of manufacturing and improve its sustainability profile. Central to the realisation of this ambition is the use of electrocatalysis, machine learning and implementation of advanced continuous flow methods. These electricity- and technology-driven reactions will develop new strategies for the generation of important classes of molecules relevant to the Australia’s pharmaceutical sector, as well as their manufacture at industrially relevant scales.

该项目旨在开发新的化学药品生产工艺。通过与Sun Pharma的合作，该公司将应对在工业反应中取代昂贵和有毒化学品的挑战，以降低制造成本并提高其可持续性。实现这一目标的核心是使用电催化，机器学习和实施先进的连续流动方法。这些电力和技术驱动的反应将开发新的战略，用于产生与澳大利亚制药部门相关的重要分子类别，以及以工业相关规模进行制造。